ArticleNAR genomics and bioinformatics2025
An ensemble-based model comprising deep learning for predicting peptide-binding residues in proteins.
Article in NAR genomics and bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Protein-peptide interactions are fundamental to numerous cellular processes and are linked to diseases like cancer when disrupted. Understanding these interactions is critical for both functional genomics and drug discovery. Despite growing availability of protein-peptide complexes, experimental methods to study them remain resource-intensive and costly. While computational approaches offer a complementary solution, their predictive accuracy is often inadequate. To overcome these limitations, we present PepENS, an ensemble model combining deep learning and traditional machine learning techniques that integrates both structural and sequence-based features from primary protein sequences. By leveraging half-sphere exposure, position-specific scoring matrices from multiple-sequence alignments, and embeddings from a pre-trained protein language model, PepENS demonstrates superior performance compared to the state-of-the-art methods. The proposed model demonstrated strong performance, achieving a precision of 0.596 and an AUC of 0.860 on the Dataset 1 test set. On the Dataset 2 test set, it attained a precision of 0.539 and an AUC of 0.846. Notably, these results reflect improvements over state-of-the-art methods in terms of precision and AUC by 2.8% and 0.5%, respectively, on Dataset 1, and by 2.3% and 2.4%, respectively, on Dataset 2. The PepENS software and associated datasets are available at https://doi.org/10.6084/m9.figshare.28490012.v2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.